335 related articles for article (PubMed ID: 29544098)
21. Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization.
Schwarz AK; Grove J; Hu K; Mee CJ; Balfe P; McKeating JA
J Virol; 2009 Dec; 83(23):12407-14. PubMed ID: 19776133
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry.
Diao J; Pantua H; Ngu H; Komuves L; Diehl L; Schaefer G; Kapadia SB
J Virol; 2012 Oct; 86(20):10935-49. PubMed ID: 22855500
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus entry into host cells.
Helle F; Dubuisson J
Cell Mol Life Sci; 2008 Jan; 65(1):100-12. PubMed ID: 17914604
[TBL] [Abstract][Full Text] [Related]
24. Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission.
Catanese MT; Loureiro J; Jones CT; Dorner M; von Hahn T; Rice CM
J Virol; 2013 Aug; 87(15):8282-93. PubMed ID: 23698298
[TBL] [Abstract][Full Text] [Related]
25. Occludin stalls HCV particle dynamics apart from hepatocyte tight junctions, promoting virion internalization.
Deffieu MS; Clément CMH; Dorobantu CM; Partiot E; Bare Y; Faklaris O; Rivière B; Ayala-Nunez NV; Baumert TF; Rondé P; Mély Y; Lucansky V; Gaudin R
Hepatology; 2022 Oct; 76(4):1164-1179. PubMed ID: 35388524
[TBL] [Abstract][Full Text] [Related]
26. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.
Liu S; Yang W; Shen L; Turner JR; Coyne CB; Wang T
J Virol; 2009 Feb; 83(4):2011-4. PubMed ID: 19052094
[TBL] [Abstract][Full Text] [Related]
27. The matrix metalloproteinase ADAM10 supports hepatitis C virus entry and cell-to-cell spread via its sheddase activity.
Carriquí-Madroñal B; Sheldon J; Duven M; Stegmann C; Cirksena K; Wyler E; Zapatero-Belinchón FJ; Vondran FWR; Gerold G
PLoS Pathog; 2023 Nov; 19(11):e1011759. PubMed ID: 37967063
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.
Sarhan MA; Chen AY; Michalak TI
PLoS One; 2013; 8(4):e62159. PubMed ID: 23626783
[TBL] [Abstract][Full Text] [Related]
29. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
Perrault M; Pécheur EI
Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
[TBL] [Abstract][Full Text] [Related]
30. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
Tong Y; Zhu Y; Xia X; Liu Y; Feng Y; Hua X; Chen Z; Ding H; Gao L; Wang Y; Feitelson MA; Zhao P; Qi ZT
J Virol; 2011 Mar; 85(6):2793-802. PubMed ID: 21177818
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus infection of neuroepithelioma cell lines.
Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F
Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002
[TBL] [Abstract][Full Text] [Related]
32. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
[TBL] [Abstract][Full Text] [Related]
33. Claudin association with CD81 defines hepatitis C virus entry.
Harris HJ; Davis C; Mullins JG; Hu K; Goodall M; Farquhar MJ; Mee CJ; McCaffrey K; Young S; Drummer H; Balfe P; McKeating JA
J Biol Chem; 2010 Jul; 285(27):21092-102. PubMed ID: 20375010
[TBL] [Abstract][Full Text] [Related]
34. The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection.
Benedicto I; Molina-Jiménez F; Bartosch B; Cosset FL; Lavillette D; Prieto J; Moreno-Otero R; Valenzuela-Fernández A; Aldabe R; López-Cabrera M; Majano PL
J Virol; 2009 Aug; 83(16):8012-20. PubMed ID: 19515778
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus receptor expression in normal and diseased liver tissue.
Reynolds GM; Harris HJ; Jennings A; Hu K; Grove J; Lalor PF; Adams DH; Balfe P; Hübscher SG; McKeating JA
Hepatology; 2008 Feb; 47(2):418-27. PubMed ID: 18085708
[TBL] [Abstract][Full Text] [Related]
36. Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner.
Fletcher NF; Sutaria R; Jo J; Barnes A; Blahova M; Meredith LW; Cosset FL; Curbishley SM; Adams DH; Bertoletti A; McKeating JA
Hepatology; 2014 Apr; 59(4):1320-30. PubMed ID: 24259385
[TBL] [Abstract][Full Text] [Related]
37. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.
Dreux M; Dao Thi VL; Fresquet J; Guérin M; Julia Z; Verney G; Durantel D; Zoulim F; Lavillette D; Cosset FL; Bartosch B
PLoS Pathog; 2009 Feb; 5(2):e1000310. PubMed ID: 19229312
[TBL] [Abstract][Full Text] [Related]
38. RNA interference and single particle tracking analysis of hepatitis C virus endocytosis.
Coller KE; Berger KL; Heaton NS; Cooper JD; Yoon R; Randall G
PLoS Pathog; 2009 Dec; 5(12):e1000702. PubMed ID: 20041214
[TBL] [Abstract][Full Text] [Related]
39. Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.
Cowton VM; Angus AGN; Cole SJ; Markopoulou CK; Owsianka A; Dunlop JI; Gardner DE; Krey T; Patel AH
J Virol; 2016 Aug; 90(16):7456-7468. PubMed ID: 27279607
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner.
Mee CJ; Farquhar MJ; Harris HJ; Hu K; Ramma W; Ahmed A; Maurel P; Bicknell R; Balfe P; McKeating JA
Gastroenterology; 2010 Mar; 138(3):1134-42. PubMed ID: 19944696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
